LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
BT-20 GSK 690693
0.04
uM
LJP5
0.8493 0.0035 0.8181 0.0029
BT-20 GSK 690693
0.12
uM
LJP5
0.8176 0.0343 0.7792 0.0358
BT-20 GSK 690693
0.37
uM
LJP5
0.7091 0.0506 0.6362 0.0609
BT-20 GSK 690693
1.11
uM
LJP5
0.6259 0.0576 0.5213 0.0717
BT-20 GSK 690693
3.33
uM
LJP5
0.5781 0.0290 0.4527 0.0358
BT-20 GSK 690693
10
uM
LJP5
0.5231 0.0227 0.3708 0.0272
BT-20 SNS-032
0.04
uM
LJP6
0.9047 0.0299 0.8846 0.0350
BT-20 SNS-032
0.12
uM
LJP6
0.3968 0.1040 0.1345 0.1551
BT-20 SNS-032
0.37
uM
LJP6
0.2008 0.0109 -0.2389 0.0389
BT-20 SNS-032
1.11
uM
LJP6
0.1669 0.0296 -0.3231 0.1000
BT-20 SNS-032
3.33
uM
LJP6
0.1648 0.0323 -0.3295 0.1076
BT-20 SNS-032
10
uM
LJP6
0.1777 0.0351 -0.2991 0.1124
BT-20 Afatinib
0.04
uM
LJP6
0.7666 0.0133 0.7043 0.0179
BT-20 Afatinib
0.12
uM
LJP6
0.8306 0.0041 0.7886 0.0097
BT-20 Afatinib
0.37
uM
LJP6
0.8508 0.0102 0.8137 0.0154
BT-20 Afatinib
1.11
uM
LJP6
0.8936 0.0267 0.8682 0.0339
BT-20 Afatinib
3.33
uM
LJP6
0.8832 0.0125 0.8546 0.0204
BT-20 Afatinib
10
uM
LJP6
0.3483 0.0934 0.0471 0.1457
BT-20 GSK1904529A
0.04
uM
LJP6
0.8568 0.0218 0.8212 0.0320
BT-20 GSK1904529A
0.12
uM
LJP6
0.9191 0.0189 0.9021 0.0209
BT-20 GSK1904529A
0.37
uM
LJP6
0.9307 0.0092 0.9157 0.0097
BT-20 GSK1904529A
1.11
uM
LJP6
0.9475 0.0215 0.9366 0.0245
BT-20 GSK1904529A
3.33
uM
LJP6
0.9667 0.0147 0.9607 0.0167
BT-20 GSK1904529A
10
uM
LJP6
1.0012 0.0199 0.9995 0.0245
BT-20 Linsitinib
0.04
uM
LJP5
0.8689 0.0120 0.8413 0.0182